Skip to content
    • Tax
      • International Tax
      • Transfer Pricing
      • Dispute Resolution
      • Business Incentives & Tax Credit
      • VAT and Indirect Taxes
      • Corporate Tax
    • Legal
      • Corporate Law
      • Litigation & Arbitration
      • Restructuring
      • Labor Law
      • Public Law
      • Data Protection
      • Sports Law
      • Compliance 231
      • Intellectual Property
      • Medical Law
    • Corporate Finance
      • Business Valuation & Modeling
      • Debt Advisory
      • Real Estate Advisory
      • Track Record
    • Multidisciplinary Services
      • M&A
      • Deal Structure & Due Diligence
      • Private Client Services
      • Global Mobility
      • Sustainability
    • Industry
      • Agribusiness
      • Energy
      • Financial Services
      • Manufacturing
      • Real Estate
      • Technology
    • About Us
      • History
      • Press
      • Charity
      • Careers
      • Whistleblowing
    • Professionals
    • News
      • Insights
      • Flash News
      • Events
      • Corporate News
    • Offices
    • Global Presence
    • Contacts
      • Work with us
Andersen Global
Andersen Consulting
  • IT
  • EN

Worldwide Locations:

  • Italy
    • Brazil
    • Canada*
    • Chile
    • France
    • Germany
    • Guatemala
    • Ireland*
    • Italy
    • Luxembourg
    • Mexico
    • Netherlands
    • Panama
    • Poland
    • Russia
    • Spain
    • Switzerland
    • United States
logo
  • Tax
    • International Tax
    • Transfer Pricing
    • Dispute Resolution
    • Business Incentives & Tax Credit
    • VAT and Indirect Taxes
    • Corporate Tax
  • Legal
    • Corporate Law
    • Litigation & Arbitration
    • Restructuring
    • Labor Law
    • Public Law
    • Data Protection
    • Sports Law
    • Compliance 231
    • Intellectual Property
    • Medical Law
  • Corporate Finance
    • Business Valuation & Modeling
    • Debt Advisory
    • Real Estate Advisory
    • Track Record
  • Multidisciplinary Services
    • M&A
    • Deal Structure & Due Diligence
    • Private Client Services
    • Global Mobility
    • Sustainability
  • Industry
    • Agribusiness
    • Energy
    • Financial Services
    • Manufacturing
    • Real Estate
    • Technology
  • About Us
    • History
    • Press
    • Charity
    • Careers
    • Whistleblowing
  • Professionals
  • News
    • Insights
    • Flash News
    • Events
    • Corporate News
  • Offices
  • Global Presence
  • Contacts
    • Work with us
Home » News » The news regarding the R&D tax credit for medicines and the introduction of the certification of the research, development, and innovation tax credit

The news regarding the R&D tax credit for medicines and the introduction of the certification of the research, development, and innovation tax credit

14 September 2022 |

Simplification decree – the R&D tax credit for medicines

In 2021, the Sostegni bis Decree introduced a specific subsidy for medicines research and development activities, including vaccines. In particular, the law provided a tax credit of 20% of the costs incurred from 1 June 2021 to 31 December 2030 for the research and development of medicines and vaccines. The Simplification Decree introduced some changes to the rule in question, eliminating the reference to “new” medicines and vaccines so that the facilitation is up to companies that carry out research and development on medicines and vaccines, even if they are not new. This novelty considerably extends the scope of the application of the subsidy. As specified by the report to the decree, the modification was necessary since the pharmaceutical sector’s research and development activity is always innovative also when the medicine is in its first production. A second significant change concerns the definition of the research and development activities eligible for the subsidy. The Simplification Decree has clarified that the provisions of Article 2 (first and second paragraphs) of the decree of the Ministry of Economic Development of 26 May 2020 apply to define these activities.

Simplification Decree – R&D tax credit certification

The Simplification Decree introduces the possibility of requesting a certification that certifies that the investments made can be qualified as expenses for research and development, technological innovation and design and aesthetic innovation. This certification eliminates any operational uncertainty in the application of the regulatory framework. Can also be requested a certification to qualify technological innovation activities aimed at achieving digital innovation 4.0 and ecological transition objectives, to apply the increase in the tax credit rate provided for by paragraphs 203, 203 quinquies and 203 sexies of article 1, Law no. 160/2019. Certification cannot be requested if tax credits violations have already been ascertained, even with accesses, inspections, verifications, or other administrative assessment activities. The certification is issued by persons who comply, in the evaluation process, with the Ministry of Economic Development guidelines. The certification has binding effects on the Financial Administration if it is not issued for an activity other than that carried out due to a false representation of the facts.

door
Andersen
Menu
  • About us
  • Professionals
  • Offices
  • Insights
  • Careers
  • Contacts
Utilities
  • Privacy and Cookies
  • Terms & Conditions
  • Compliance 231
  • Andersen Global

©Andersen Tax LLC and Andersen Italia. Andersen Italia is the Italian member firm of Andersen Global, a Swiss verein comprised of legally separate, independent member firms located throughout the world providing services under their own name or the brand "Andersen,” "Andersen Tax," or "Andersen Tax & Legal," or "Andersen Legal." Andersen Global does not provide any services and has no responsibility for any actions of the member firms, and the member firms have no responsibility for any actions of Andersen Global. Your use of this website is subject to the terms and conditions governing it. Please read these terms and conditions before using the website.